Oxford startet klinische Studie für Ebola-Impfstoff gegen Bundibugyo-Stamm
LONDON (IT BOLTWISE) – Oxford hat die erste klinische Studie für einen Impfstoff gegen den Bundibugyo-Ebola-Stamm gestartet. Die Maßnahme zielt darauf, einen Virus einzudämmen, der laut Angaben der…
Read the full articleYou might also wanna read
Ebola: Oxford inicia primeiro teste em humanos de vacina contra o vírus causador do surto atual
O Oxford Vaccine Group, da Universidade de Oxford na Inglaterra, iniciou o primeiro ensaio clínico de Fase I do mundo — o BD-Ebov — de uma v
Uniklinik Frankfurt: Zweiter Ebola-Patient zur Behandlung gelandet
Knapp zwei Monate nach dem ersten Fall ist erneut ein US-Bürger mit Ebola nach Deutschland ausgeflogen worden. Für die Virusvariante gibt es
Oxford begins first human trial of Bundibugyo Ebola vaccine
July 13 (Reuters) - The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accel
Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate efforts to co
Vaccine trial launched in Oxford in response to deadly outbreak
A vaccine trial is under way as part of efforts to tackle the Bundibugyo ebolavirus.
Oxford, Serum Institute Launch First Human Trial for New Ebola Vaccine
Oxford and Serum Institute have launched the first human trial of a vaccine targeting the deadly Bundibugyo strain of Ebola virus.
Comments
Sign in to join the conversation.
No comments yet. Be the first.